IDEAYA Biosciences (IDYA) Return on Sales (2020 - 2025)
IDEAYA Biosciences' Return on Sales history spans 6 years, with the latest figure at 8.7% for Q4 2025.
- For Q4 2025, Return on Sales rose 1190.0% year-over-year to 8.7%; the TTM value through Dec 2025 reached 14.65%, up 3206.0%, while the annual FY2025 figure was 0.73%, 4598.0% up from the prior year.
- Return on Sales for Q4 2025 was 8.7% at IDEAYA Biosciences, up from 29.84% in the prior quarter.
- Across five years, Return on Sales topped out at 0.02% in Q3 2022 and bottomed at 57.29% in Q3 2024.
- The 5-year median for Return on Sales is 7.63% (2022), against an average of 14.91%.
- The largest annual shift saw Return on Sales crashed -5312bps in 2024 before it surged 2745bps in 2025.
- A 5-year view of Return on Sales shows it stood at 6.2% in 2021, then fell by -6bps to 6.57% in 2022, then tumbled by -63bps to 10.68% in 2023, then crashed by -93bps to 20.59% in 2024, then skyrocketed by 58bps to 8.7% in 2025.
- Per Business Quant, the three most recent readings for IDYA's Return on Sales are 8.7% (Q4 2025), 29.84% (Q3 2025), and 54.89% (Q2 2025).